WASHINGTON (AP) — The Supreme Court seemed skeptical Tuesday of allowing generic drug manufacturers to be sued in state court for a drug’s design defects if federal officials approved the brand-name version the generic drug copied.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.